SBIR Advance grants are used for commercialization activities that accelerate business development and improve company opportunities for Phase II and Phase III federal awards, and for investor funding.
Applicants for SBIR Advance may receive up to $75K for Phase I and $100K for Phase II.
Key Dates
Letter of Intent (LOI) – Due January 3, 2019, 12:00 p.m.
Full Application – Due January 17, 2019, 12:00 p.m.
NIH Funding Acknowledgment:Important Reminder – Please acknowledge the NIH when publishing papers, patents, projects, and presentations resulting from the use of CTSI resources by including the NIH Funding Acknowledgement.
